John Wiley & Sons/$WLYB
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About John Wiley & Sons
John Wiley & Sons Inc is a publisher and a trusted leader in research and learning. The company segment includes: Research, which includes the reporting lines of Research Publishing and Research Solutions, and Learning, which includes the Academic and Professional reporting lines and consists of publishing, courseware, and assessments. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.
- Ticker
- $WLYB
- Sector
- Communication
- Primary listing
- NYSE
- Employees
- 4,500
- Headquarters
- Hoboken, United States
- Website
- www.wiley.com
WLYB Metrics
BasicAdvanced
$2.7B
14.24
$3.77
0.77
$1.42
2.66%
Price and volume
Market cap
$2.7B
Beta
0.77
52-week high
$55.51
52-week low
$29.16
Average daily volume
3.2K
Dividend rate
$1.42
Financial strength
Current ratio
0.636
Quick ratio
0.46
Long term debt to equity
1.688
Total debt to equity
1.725
Dividend payout ratio (TTM)
37.11%
Interest coverage (TTM)
6.05%
Profitability
EBITDA (TTM)
349.311
Gross margin (TTM)
74.60%
Net profit margin (TTM)
11.90%
Operating margin (TTM)
16.99%
Effective tax rate (TTM)
-7.24%
Revenue per employee (TTM)
$370,000
Management effectiveness
Return on assets (TTM)
6.25%
Return on equity (TTM)
25.91%
Valuation
Price to earnings (TTM)
14.237
Price to revenue (TTM)
1.671
Price to book
3.33
Price to tangible book (TTM)
-1.83
Price to free cash flow (TTM)
13.404
Free cash flow yield (TTM)
7.46%
Free cash flow per share (TTM)
4.009
Dividend yield (TTM)
2.65%
Forward dividend yield
2.66%
Growth
Revenue change (TTM)
-0.27%
Earnings per share change (TTM)
112.11%
3-year revenue growth (CAGR)
-5.64%
10-year revenue growth (CAGR)
-0.25%
3-year earnings per share growth (CAGR)
54.09%
10-year earnings per share growth (CAGR)
4.37%
3-year dividend per share growth (CAGR)
0.71%
10-year dividend per share growth (CAGR)
1.63%
What the Analysts think about WLYB
Majority rating from 1 analysts.
| Month | Buy | Hold | Sell | Analysts | Majority rating |
|---|---|---|---|---|---|
| July 2023 | 1 | 0 | 0 | 1 | Buy |
| August 2023 | 1 | 0 | 0 | 1 | Buy |
| September 2023 | 1 | 0 | 0 | 1 | Buy |
| October 2023 | 1 | 0 | 0 | 1 | Buy |
| November 2023 | 1 | 0 | 0 | 1 | Buy |
| December 2023 | 1 | 0 | 0 | 1 | Buy |
| January 2024 | 1 | 0 | 0 | 1 | Buy |
| February 2024 | 1 | 0 | 0 | 1 | Buy |
| March 2024 | 1 | 0 | 0 | 1 | Buy |
| April 2024 | 1 | 0 | 0 | 1 | Buy |
| May 2024 | 1 | 0 | 0 | 1 | Buy |
| June 2024 | 1 | 0 | 0 | 1 | Buy |
Bulls say / Bears say
Research Publishing revenue rose 12% in Q1, or 6% excluding Emerald, while the segment’s adjusted EBITDA margin expanded by 130 basis points. This points to solid underlying demand and improving profitability in Wiley’s core research business. (SEC)
Wiley generated $14 million of AI revenue in Q1 and says it is on track to exceed $50 million for fiscal 2027. Its inclusion in the US Department of Energy’s Genesis Mission gives Wiley a route to put its scientific content and tools into wider research and AI workflows. (SEC, Morningstar)
The Emerald acquisition expands Wiley’s research catalogue and is expected to add $78 million of revenue over 11 months of fiscal 2027. Wiley expects it to lift adjusted EPS this year, with targeted cost synergies of $30 million by year three. (SEC)
Learning revenue fell 19% in Q1 and adjusted EBITDA dropped 55%, reflecting weak consumer and corporate demand as well as the comparison with prior-year AI licensing. The scale of the decline raises questions about whether this segment can stabilise as management expects. (SEC)
AI licensing income can be volatile: Wiley recognised $14 million in Q1 compared with $29 million in the prior-year quarter. That swing weighed on reported revenue and earnings, and makes the growth case dependent on converting licensing deals into steadier recurring income. (SEC)
The Emerald purchase has increased financial leverage: net debt-to-EBITDA was 2.7 times at quarter-end, up from 1.9 times a year earlier. Higher debt also contributed to increased interest expense, leaving less room if the expected acquisition benefits or cash-flow recovery fall short. (SEC)
Data summarised monthly by Lightyear AI. Last updated on 7 Oct 2026.
WLYB Financial Performance
Revenues and expenses
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.